Full Text View
Tabular View
No Study Results Posted
Related Studies
Reconstruction of 12-Lead Electrogram From Intracardiac Signals From Defibrillators During or After Implantation
This study is currently recruiting participants.
Verified by University of Pittsburgh, April 2009
First Received: April 28, 2009   No Changes Posted
Sponsored by: University of Pittsburgh
Information provided by: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00890461
  Purpose

The purpose of this study is to reconstruct a 12-lead electrocardiogram (ECG) from intracardiac (IC) electrograms (EGM) obtained from defibrillator devices (ICD). The purpose of such a reconstruction is to allow the use of IC EGM for diagnosis of clinical conditions for which ECG have historically been used, and to test the feasibility of a reconstruction technique for the standard 12-lead or extended electrocardiogram from electrical potentials obtained from inside a patient.


Condition
Implantation of an Internal Defibrillator

U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Reconstruction of 12-Lead Electrogram From Intracardiac Signals From Defibrillators During or After Implantation

Further study details as provided by University of Pittsburgh:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 30
Study Start Date: November 2007
Groups/Cohorts
Defibrillator
The subject population will be obtained by approaching the Principal and Co- Investigators' patients who have been referred for ICD implantation. This population ranges in age from 18 years on, and includes both males and females. A maximum of 30 subjects will be enrolled in this study.

Detailed Description:

Reconstructing a 12-lead surface ECG from intracardiac EGM vectors of patients implanted with defibrillators can be of great value. It allows implantable devices that have thus far been used exclusively for arrhythmia detection and treatment, to be used for diagnostic purposes in similar ways as the ECG.

The advantage of the reconstruction process is that it provides real-time continuous monitoring, which can be used for multiple purposes, including but not limited to:

  1. Ischemia detection
  2. Myocardial Infarction detection
  3. Electrolyte abnormalities detection
  4. Assessment of effect of medications
  5. Improved rhythm discrimination
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Subjects will be identified by their cardiologist who is also an investigator on this study at the time they are evaluated for an ICD implantation.

Once it has been determined during the course of the patient's regular clinical care that he or she requires an ICD, they will be approached for enrollment into the study by the physician investigator and the clinical research coordinator.

Criteria

Inclusion Criteria:

  1. Subjects must be at least 18 years of age.
  2. Subjects must be referred for ICD implantation.
  3. Subjects must be willing to sign informed consent.

Exclusion Criteria:

  1. Subject is unable or unwilling to sign informed consent.
  2. Subject is pacemaker dependent.
  3. Subject is pregnant as indicated by standard clinical procedures prior to implant.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00890461

Contacts
Contact: Samir F Saba, MD 412-647-6272 sabas@upmc.edu
Contact: Susan A Mularski, BS 412-648-6024 mularskisa@upmc.edu

Locations
United States, Pennsylvania
UPMC Presbyterian Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact: Susan A Mularski, BS     412-648-6024     mularskisa@upmc.edu    
Principal Investigator: Samir F. Saba, MD            
Sub-Investigator: Stuart Mendenhall, MD            
UPMC Shadyside Recruiting
Pittsburgh, Pennsylvania, United States, 15232
Contact: Susan A Mularski, BS     412-648-6024     mularskisa@upmc.edu    
Principal Investigator: Samir F Saba, MD            
Sub-Investigator: Stuart G Mendenhall, MD            
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: Samir F Saba, MD University of Pittsburgh
  More Information

No publications provided

Responsible Party: University of Pittsburgh ( Samir Saba, M.D. )
Study ID Numbers: PRO07080211
Study First Received: April 28, 2009
Last Updated: April 28, 2009
ClinicalTrials.gov Identifier: NCT00890461     History of Changes
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on May 07, 2009